Roivant Sciences to Present at the 38th Annual J.P. Morgan Healthcare ConferenceHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Roivant Sciences to Present at the 38th Annual J.P. Morgan Healthcare ConferencePR NewswireJanuary 8, 2020ReblogShareTweetShareNEW YORK and BASEL, Switzerland, Jan. 8, 2020 /PRNewswire/ -- Roivant Sciences today announced that Vivek Ramaswamy, Founder and Chief Executive Officer of Roivant, will present an overview of recent developments and future directions for the business at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.The company's presentation is scheduled to begin at 10:30 a.m. PT on Tuesday, January 14, 2019 at the Westin St. Francis.Roivant recently announced the close of its transaction forming a strategic alliance with Sumitomo Dainippon Pharma. The company will discuss this transaction and other business updates during its presentation.About Roivant SciencesRoivant Sciences aims to improve health by rapidly delivering innovative medicines and technologies to patients. Roivant does this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology to drive greater efficiency in R&D and commercialization.For more information, please visit www.roivant.com.Media Contact:Paul Davispaul.davis@roivant.comCisionMoreView original content:http://www.prnewswire.com/news-releases/roivant-sciences-to-present-at-the-38th-annual-jp-morgan-healthcare-conference-300983192.htmlSOURCE Roivant SciencesReblogShareTweetShareRecently ViewedYour list is empty.What to Read Next/C O R R E C T I O N -- National Kidney Foundation/PR NewswireNatural Landmarks Preservation Contest Highlights What's Worth SavingPR NewswireBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoWhy BE Group AB (publ) (STO:BEGR) Is A Dividend RockstarSimply Wall St.Most face masks won’t protect you from the coronavirusYahoo Finance'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoAsian markets continue to slump, as Nikkei enters correction territoryMarketWatchRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo Finance